Mimedx (MDXG) Accounts Payables (2010 - 2026)
Mimedx (MDXG) posted Accounts Payables of $8.3 million for Q2 2026, down 27.66% sequentially from $11.5 million in Q1 2026, and down 2.42% YoY from $8.5 million in Q2 2025.
Mimedx (MDXG) Accounts Payables (2010 - 2026) Analysis & Trends
Mimedx has reported Accounts Payables for 17 years, with the latest figure at $8.3 million in Q2 2026.
- Quarterly Accounts Payables fell 2.42% year-over-year to $8.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.3 million (down 2.42% YoY) and the FY2025 annual result came in at $14.5 million, up 96.09% from the prior year.
- Accounts Payables declined to $8.3 million in Q2 2026 per MDXG's latest filing, from $11.5 million in the prior quarter.
- Over five years, Accounts Payables peaked at $14.5 million in Q4 2025 and troughed at $6.9 million in Q3 2024.
- A 5-year average of $9.0 million and a median of $8.5 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables decreased 24.49% in 2024, then jumped 96.09% in 2025.
- Over 5 years, Accounts Payables stood at $8.5 million in 2022, then increased by 7.03% to $9.0 million in 2023, then decreased by 18.11% to $7.4 million in 2024, then surged by 96.09% to $14.5 million in 2025, then slumped by 42.92% to $8.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $8.3 million, $11.5 million, and $14.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 8.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.29 Mn |
| Mar 31, 2026 | 11.46 Mn |
| Dec 31, 2025 | 14.53 Mn |
| Sep 30, 2025 | 11.42 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 7.41 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | 9.05 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 8.15 Mn |
| Mar 31, 2023 | 7.82 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 8.82 Mn |
| Jun 30, 2022 | 8.08 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 7.39 Mn |
| Sep 30, 2021 | 6.88 Mn |